Cargando…
Primary malignant melanoma of the vagina: A case report
Malignant primary melanoma of the vagina (PMV) is a rare type of non-cutaneous melanoma often discovered in postmenopausal women. PMV has a very aggressive disease course and a poor prognosis. The best course of treatment is not presently agreed upon. In this report, we describe the case of a 68-yea...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505967/ https://www.ncbi.nlm.nih.gov/pubmed/37727370 http://dx.doi.org/10.1016/j.gore.2023.101266 |
_version_ | 1785107019714265088 |
---|---|
author | Sticca, Giancarlo Misheva, Bojana Sebajang, Herawaty Samouelian, Vanessa Jamal, Rahima |
author_facet | Sticca, Giancarlo Misheva, Bojana Sebajang, Herawaty Samouelian, Vanessa Jamal, Rahima |
author_sort | Sticca, Giancarlo |
collection | PubMed |
description | Malignant primary melanoma of the vagina (PMV) is a rare type of non-cutaneous melanoma often discovered in postmenopausal women. PMV has a very aggressive disease course and a poor prognosis. The best course of treatment is not presently agreed upon. In this report, we describe the case of a 68-year-old woman presenting with a malignant PMV and its subsequent management. The patient presented with right vaginal pain, abnormal vaginal bleeding and a new vaginal mass. A PET scan identified a 28 × 38 mm hypermetabolic vaginal lesion, without nodal involvement or distant metastasis. A posterior exenteration type 2B was performed, including the anal mucosa. Sentinel lymph node dissection, vaginal and rectal resection as well as a terminal colostomy were also carried out. Final staging was FIGO stage III and T4bN1. Four months later, the patient presented with a recurrent vaginal bleed and intra-vaginal induration. Imaging revealed loco-reginal recurrence at the site of the primary malignancy with countless metastases. The patient opted for palliative care given the early disseminated recurrence and her multiple comorbidities. We review the treatment options for PMV, mainly the importance of surgery as the mainstay of treatment as well as the interest of adding checkpoint inhibitor immunotherapy or targeted therapy to the treatment plan. We also summarize the characteristics of PMV and its main prognostic factors. |
format | Online Article Text |
id | pubmed-10505967 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-105059672023-09-19 Primary malignant melanoma of the vagina: A case report Sticca, Giancarlo Misheva, Bojana Sebajang, Herawaty Samouelian, Vanessa Jamal, Rahima Gynecol Oncol Rep Survey Article Malignant primary melanoma of the vagina (PMV) is a rare type of non-cutaneous melanoma often discovered in postmenopausal women. PMV has a very aggressive disease course and a poor prognosis. The best course of treatment is not presently agreed upon. In this report, we describe the case of a 68-year-old woman presenting with a malignant PMV and its subsequent management. The patient presented with right vaginal pain, abnormal vaginal bleeding and a new vaginal mass. A PET scan identified a 28 × 38 mm hypermetabolic vaginal lesion, without nodal involvement or distant metastasis. A posterior exenteration type 2B was performed, including the anal mucosa. Sentinel lymph node dissection, vaginal and rectal resection as well as a terminal colostomy were also carried out. Final staging was FIGO stage III and T4bN1. Four months later, the patient presented with a recurrent vaginal bleed and intra-vaginal induration. Imaging revealed loco-reginal recurrence at the site of the primary malignancy with countless metastases. The patient opted for palliative care given the early disseminated recurrence and her multiple comorbidities. We review the treatment options for PMV, mainly the importance of surgery as the mainstay of treatment as well as the interest of adding checkpoint inhibitor immunotherapy or targeted therapy to the treatment plan. We also summarize the characteristics of PMV and its main prognostic factors. Elsevier 2023-09-07 /pmc/articles/PMC10505967/ /pubmed/37727370 http://dx.doi.org/10.1016/j.gore.2023.101266 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Survey Article Sticca, Giancarlo Misheva, Bojana Sebajang, Herawaty Samouelian, Vanessa Jamal, Rahima Primary malignant melanoma of the vagina: A case report |
title | Primary malignant melanoma of the vagina: A case report |
title_full | Primary malignant melanoma of the vagina: A case report |
title_fullStr | Primary malignant melanoma of the vagina: A case report |
title_full_unstemmed | Primary malignant melanoma of the vagina: A case report |
title_short | Primary malignant melanoma of the vagina: A case report |
title_sort | primary malignant melanoma of the vagina: a case report |
topic | Survey Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505967/ https://www.ncbi.nlm.nih.gov/pubmed/37727370 http://dx.doi.org/10.1016/j.gore.2023.101266 |
work_keys_str_mv | AT sticcagiancarlo primarymalignantmelanomaofthevaginaacasereport AT mishevabojana primarymalignantmelanomaofthevaginaacasereport AT sebajangherawaty primarymalignantmelanomaofthevaginaacasereport AT samouelianvanessa primarymalignantmelanomaofthevaginaacasereport AT jamalrahima primarymalignantmelanomaofthevaginaacasereport |